TCL Archive As FDA Weighs its Options on Morcellation, Debate Erupts Over Harvard Device Study November 21, 2014
TCL Archive Bush Names Leffall Cancer Panel Chairman, Appoints Cyclist Armstrong To Panel May 31, 2002
TCL Archive FDA Approves Gemzar For Ovarian Cancer, Contradicting ODAC Recommendation; Continues Agency Trend to Recognize Progression-Free Survival As An Endpoint. July 21, 2006
TCL Archive The Meeting Worth Lobbying For: A “PRG” For Disease-Specific Review; NCI Plans Six. June 23, 2000
